2,4-dinitrophenol (DNP) vs semaglutide

2,4-dinitrophenol (DNP) (F-tier) vs semaglutide (S-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

2,4-dinitrophenol (DNP) · tier F

DNP is an oral small-molecule mitochondrial uncoupler, not a peptide. People seek it for rapid weight loss. The same mechanism can cause lethal hyperthermia and cardiovascular collapse.

DNP can cause weight loss. Uncontrolled 1930s clinical series reported 2 to 3 pounds weekly, but the same uncoupling has caused fatal hyperthermia and cardiovascular collapse, and no established antidote stops it.

at least 62 published deaths counted in a 2011 medical-literature review · half-life not structured; no routine-use human value · weight loss

semaglutide · tier S

A GLP-1 receptor agonist with current US injection and oral products for distinct labeled uses.

Strong obesity, cardiovascular, kidney, and MASH evidence, but each result belongs to its own product, route, population, and label.

14.9% STEP 1 mean weight change · half-life ~1 week · weight loss

at a glance

• 2,4-dinitrophenol (DNP): tier F · at least 62 published deaths counted in a 2011 medical-literature review
• semaglutide: tier S · 14.9% STEP 1 mean weight change

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.